Sophie Leff

Associate

紐約 + 1.212.326.3685

Sophie Leff focuses her practice on civil litigation and investigations, particularly in the health care and life sciences sectors. She has experience defending clients in investigations and litigation brought by federal agencies and qui tam whistleblowers under the False Claims Act (FCA) and similar fraud and abuse laws. Sophie also has counseled health systems, provider networks, medical device manufacturers, and digital health and health technology companies on regulatory and compliance matters.

While clerking on the United States Court of Appeals for the Sixth Circuit, Sophie gained experience in a wide range of subject areas and litigation postures, including contract, consumer protection, and securities law, as well as mass tort, products liability, and employment discrimination disputes. As a clerk, Sophie developed particular familiarity with doctrine and mechanics of class certification.

Sophie maintains an active pro bono practice. She represents clients seeking a variety of immigration relief at the trial and appellate levels and also works on pro bono criminal appeals and habeas cases.

執業經驗

  • Diebold Nixdorf successfully restructures over $2.7 billion in funded debt and completes the first-ever dual proceeding under the U.S. bankruptcy code and Dutch restructuring law in 71 daysIn the first-ever cross border restructuring involving dual main proceedings under chapter 11 of the U.S. Bankruptcy Code and a scheme of arrangement (the "Dutch Scheme") under the Dutch Act on Confirmation of Extrajudicial Plans (Wet Homologatie Onderhands Akkoord ("WHOA")), and the first-ever chapter 15 recognition of Dutch Scheme proceedings and a sanctioned WHOA reorganization plan (the "WHOA Plan"), Jones Day represented Diebold Nixdorf, Incorporated ("Diebold") and certain of its U.S. and Canadian subsidiaries (the "Debtors") in connection with (i) the prepackaged chapter 11 cases of In re Diebold Holding Company, LLC, et al., (Case No. 23-90602-DRJ) commenced on June 1, 2023, in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"); (ii) the Dutch Scheme, commenced on June 1, 2023 by Diebold Nixdorf Dutch Holding B.V. (the "Dutch Issuer") in the District Court of Amsterdam (the "Dutch Court"), and (iii) the chapter 15 proceedings before the Bankruptcy Court commenced by the foreign representative of the Dutch Issuer, wherein the Bankruptcy Court recognized the Dutch Scheme proceeding as a foreign main proceeding and recognized and extended comity to the WHOA Plan that was sanctioned by the Dutch Court.